mdm2: a bridge over the two tumour suppressors, p53 and Rb

D B Yap1, J K Hsieh, F S Chan

  • 1Ludwig Institute for Cancer Research, Imperial College School of Medicine, St. Mary's campus, Norfolk Place, London, W2 1PG, UK.

Oncogene
|January 5, 2000
PubMed

Insights

The p53 and Rb tumor suppressor pathways are frequently inactivated in human cancers. Their interaction, mediated by mdm2, reveals how they cooperate to regulate apoptosis and highlights the link between p53

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cellular Biology

Background:

  • The p53 and Retinoblastoma (Rb) tumor suppressor pathways are critical regulators of cell growth and are inactivated in most human cancers.
  • Cross-talk between p53 and Rb pathways is extensive, but the mdm2-Rb interaction provides a direct mechanistic link between these two key suppressors.
  • Recent research has identified a novel trimeric complex, Rb-mdm2-p53, offering functional insights into their collaborative roles.

Purpose of the Study:

  • To review the properties of the Rb-mdm2-p53 trimeric complex.
  • To explore the functional relationship between p53's apoptotic and transrepression functions.
  • To discuss the potential uncoupling of p53's apoptotic and transactivation functions.

Main Methods:

  • Literature review of studies on the Rb-mdm2-p53 trimeric complex.
  • Analysis of evidence linking p53's apoptotic function to its transrepression activity.
  • Discussion of research on the dissociation of p53's apoptotic and transactivation functions.

Main Results:

  • The Rb-mdm2-p53 complex provides functional insights into how p53 and Rb cooperate in regulating p53-induced apoptosis.
  • Evidence suggests a strong link between the apoptotic function of p53 and its capacity for transrepression.
  • The study discusses the implications of uncoupling p53's apoptotic and transactivation functions.

Conclusions:

  • The interaction between p53, Rb, and mdm2 is crucial for understanding tumor suppression.
  • p53's apoptotic role is intrinsically connected to its transrepression activity.
  • Understanding the dissociation of these functions may reveal new therapeutic strategies for cancer.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...